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Multidimensional Chemical Genetic Analysis
of Diversity-Oriented Synthesis-Derived
Deacetylase Inhibitors Using Cell-Based Assays
rectly disrupt protein-protein interactions, and the ex-
tended temporal scale required for RNAi limits the gen-
eral application of this approach.
Diversity-oriented organic synthesis is increasingly
providing complex and effective small molecule modula-
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4Howard Hughes Medical Institute these molecules have specific effects upon biological
systems (at various levels of resolution from proteins toHarvard University
12 Oxford Street whole organisms), and (2) determining the structural and
physiochemical properties of molecules that specify as-Cambridge, Massachusetts 02138
sociated biological activities. These efforts will benefit
from the systematic “mapping” of small molecules to
positions in a multidimensional chemical space derivedSummary
from molecular and/or biological descriptors. Toward
this end, a multidimensional chemical genetic (MDCG)Systematic chemical genetics aims to explore the
approach is being developed, using high-throughputspace representing interactions between small mole-
phenotypic assays to partition chemical space into re-cules and biological systems. Beyond measuring bind-
gions of different biological activities as well as to parti-ing interactions and enzyme inhibition, measuring
tion biological space into regions with different chemicalchanges in the activity of proteins in intact signaling
activity.networks is necessary. Toward this end, we are parti-
Similar to other research endeavors requiring multidi-tioning chemical space into regions with different bio-
mensional analysis, chemical genetic information canlogical activities using a panel of cell-based assays
be arranged in a matrix, denoted S, consisting of anand small molecule “chemical genetic modifiers.”
ordered array of columns and rows (Figure 1A). EachHerein, we report on the use of this methodology for
column (yj) in S is a descriptor corresponding to a cell-the discovery of 617 small molecule inhibitors of his-
based or biochemical assay and is denoted by a bold-tone deacetylases from a multidimensional screen of
face, lowercase letter subscripted j (where j  1 to n ).an encoded, diversity-oriented synthesis library. Fol-
Similarly, each row (xi) in S corresponds to a chemicallowing decoding of chemical tags and resynthesis, we
and is denoted by a boldface, lowercase letter sub-demonstrate the selectivity of one inhibitory molecule
scripted i (where i  1 to m ). Accordingly, an element(tubacin) toward -tubulin deacetylation and another
(m, n ) of S encodes information about chemical m for(histacin) toward histone deacetylation. These small
descriptor n.molecules will facilitate dissecting the role of acetyla-
Geometrically, considering the elements of S as coor-tion in a variety of cell biological processes.
dinates, chemicals (or assays) can be modeled as vec-
tors, xi  [e1, e2,…,en], in an n- (or m-) dimensional vectorIntroduction space. By defining the Euclidean distance D between two
vectors (e.g., x1 and x2) in this vector space to be D122 Models of complex biological systems highlight the in-
 [(x1 – x2)2], the space of chemical genetic observationterdependent and robust nature of biochemical net- can be considered as a metric space. That means the
works [1–4]. The development of experimental methods relative distance D between chemicals xi (or assays yj),to modulate selectively the functions of individual nodes in other words their proximity becomes informative with
(representing proteins) in these networks is a central respect to similarity between the particular descriptors
aim of chemical genetics. Although chemical genetics considered. Accordingly, in analyzing chemical genetic
is modeled after classical genetics, especially with re- data obtained from screening small molecule libraries,
spect to the logic of phenotype-based screening, it dif- small molecules xi (or assays yj) can be considered tofers from classical genetics in the use of small mole- be functionally similar if they are closely positioned (i.e.,
cules, rather than mutations, to perturb the function(s) within a specified radius) in the underlying descriptor
of gene products [5–10]. Given the temporal control of- space. Since similarity between small molecules is de-
fered by small molecules and the ability to use combina- termined by the pattern of interaction with biological
tions of small molecule modulators, chemical genetics systems, the corresponding distance metric D comple-
promises to complement the use of pure genetic analy- ments the definition of similarity obtained from calcu-
sis to study a wide range of biological systems. Although lated molecular descriptors based on chemical struc-
the use of ribonucleic acid interference (RNAi) and re- ture. Furthermore, since similarity in cell-based assays
lated phenomena now provides a powerful reverse ge- results from patterns of small molecules interacting with
netic approach for functional genomics, the inability to expressed gene products, the corresponding distance
selectively target individual functions of proteins, to di- metric D complements the definition of similarity ob-
tained from DNA sequence or gene expression analysis.
As part of this ongoing effort, we describe the devel-*Correspondence: sls@slsiris.harvard.edu
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Figure 1. Overview of Multidimensional Chemical Genetic Analysis
(A) The three-part protocol involved in screening of 7392 diversity-oriented synthesis-derived deacetylase inhibitors. Chemical genetic informa-
tion is obtained as “object observations” and arranged in a matrix, denoted by S. Each column (yj) in S is a descriptor which corresponds to
a phenotype from a cell-based or biochemical assay. Each row (xi) in S is an object which corresponds to a chemical. An element (m, n ) of
S encodes information about chemical m for descriptor n.
(B) Summary of small molecules based upon a 1,3-dioxane structure and combinatorics of the full library.
(C) Structure of ITSA1, a chemical genetic modifier that suppresses TSA-induced histone and -tubulin acetylation [21].
(D) Summary of screens performed and abbreviations used for the assays.
opment of new cytoblot assays that use posttransla- plied to identify selective inhibitors of the family of zinc-
dependent deacetylase enzymes typified by the histonetional chemical modifications as markers of cellular
state [11]. In this system, MDCG analysis has been ap- deacetylases (HDACs) [12–20]. In a companion paper
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to this one [21], we describe the motivations behind the Following cytoblot analysis, statistical properties
were calculated for each of the screening datasets (Fig-use of chemical genetic modifiers (e.g., ITSA1, “inhibitor
of trichostatin A-1”) in dissecting the role of HDACs in ure 1A, part II). Using an empirically determined thresh-
old for bioactivity, we constructed a discrete model ofregulating cell cycle progression. In another paper [22],
one selective inhibitor of -tubulin deacetylation (tu- these data in the form of a chemical genetic network
and calculated topological properties of the resultingbacin) discovered in this analysis is used to dissect the
function of HDAC6 as an -tubulin deacetylase [23] in graph. To determine global relationships between assay
variables and regions of different bioactivity, both clus-mediating cell cycle progression, microtubule stability, and
cell motility. Finally, we have begun dissecting the struc- tering and principal component analysis were used.
Subsequently, small molecules of interest were retestedtural and physiochemical basis for the in vivo selectivity
of HDAC inhibitors discovered in this analysis [24]. from the sample stock solution by fluorescence micros-
copy (Figure 1A, part III). This secondary assay allowed
us to assess the observed selectivity in an independent
Results manner and to determine whether small molecule “hits”
had other effects on cellular morphology, viability, and
Library Design and Outline of Multidimensional chromatin conformation.
Chemical Genetic Analysis
The stereoselective synthesis of a small molecule library
based on a 1,3-dioxane diversity element has been de- Screening Results
A summary of the cell-based assays performed is shownscribed previously (Figure 1B) [25]. Each small molecule
contains a metal-chelating functional group (o-aminoan- in Figure 1D. Following robotic pin transfer [29], the 1,3-
dioxane-based small molecules (2–5 M, dependingilide, carboxylic acid, or hydroxamic acid) at position
R4. Since HDACs are zinc-dependent hydrolases [26], upon efficiency of synthesis and amount of compound
pin transferred) were incubated with cells for a totalmetal chelators “bias” the library toward deacetylase
inhibition. Prior to screening the full 7,392-member li- of 18 hr. The entire collection of 7392 molecules was
screened (in duplicate) in the AcTubulin and AcLysinebrary, a pilot screen of five representative small mole-
cules indicated that these compounds inhibited HDACs cytoblot assays (e.g., Figure 2A). A subset of the library
was then further evaluated in three other acetylation-1, 4, and 6 in vitro, and four out of five also induced
-tubulin acetylation (low M range; data not shown) based assays, including one involving the suppressor
ITSA1. Correlation between replicates was strong, with[27]. Consequently, since determining the relative activ-
ity and selectivity of these small molecules was a main r  0.84 (p value  0.05) representing the minimum
correlation between duplicate plates containing hydrox-objective, we focused on identifying compounds that
caused a differential increase in -tubulin acetylation amic acids (Figure 2B). Values from replicates were stan-
dardized to a control from each plate, averaged, andand histone acetylation as indicators of cytoplasmic and
nuclear deacetylase inhibition, respectively. Log2 transformed to reduce the skewness and kurtosis
prior to fitting to a normal distribution. Statistical proper-Based on our previous success using miniaturized
cytoblot cell-based assays [9, 11], we developed a ties pertaining to each R4 biasing element in the library
are shown in the box plots in Figure 2C. Since diversitythree-part screen compatible with the amount of com-
pound available from a “one bead-one stock solution” position R4 was encoded spatially as well as by tagging,
we were able to determine the relative distribution ofapproach to chemical genetics [29–31]. Using antibod-
ies specific to the acetylated state of -tubulin and acet- bioactive small molecules amongst the three biasing
elements. Under the assumption of equal synthetic effi-ylated histones (Figure 1A, part I) [27], assay conditions
were optimized separately using HDAC inhibitor tricho- ciency and purity, the hydroxamic acids were assessed
to be most active and the o-aminoanilides least activestatin A (TSA) as a positive control for inhibition of both
histone and -tubulin deacetylation [13, 21]. The anti- in both the AcTubulin and AcLysine assays (Figure 2D).
After separately fitting relative acetylation data frombody utilized to evaluate the level of histone acetylation
(anti-acetylated lysine antibody) reacts with a variety of the AcTubulin and AcLysine assays to a normal distribu-
tion, a value corresponding to a 1.5-fold or greater in-proteins by Western blotting. However, under cytoblot
conditions, this antibody recognized predominantly nu- crease was chosen as the criterion for bioactivity (see
Supplemental Table S1 at http://www.chembiol.com/clear proteins, as judged by fluorescence microscopy.
Thus, the acetylated lysine cytoblot is effectively a mea- cgi/content/full/10/5/383/DC1 or write to chembiol@cell.
com for a PDF). Accordingly, 617 small molecules weresure of histone acetylation, as histones are the predomi-
nant nuclear acetylated proteins. The chemical genetic active in at least one assay, with 475 small mole-
cules active in the AcTubulin assay and 344 small mole-modifier ITSA1 (Figure 1C), which suppresses (reduces)
the ability of TSA to increase acetylation levels of both cules active in the AcLysine assay (Figure 2D). Overall,
a significant correlation (r  0.39, p value  0.05) exists-tubulin and histones [21], was introduced as another
variable in our screening strategy. ITSA1 suppresses between the normalized acetylation level in the AcTu-
bulin versus the AcLysine assays (Figure 3A). Indeed,hydroxamic acid-based (such as TSA) but not epoxy
ketone-based (such as trapoxin) deacetylase inhibitors. deconvolution of the 617 hit compounds into those spe-
cific for the AcTubulin (273) or the AcLysine (142) assayThus, using ITSA1 in our screen allowed us to identify
both “TSA-like” and “trapoxin-like” small molecule de- revealed that 202 (33%) molecules scored in both assays
(Figures 3B and 3C).acetylase inhibitors, based on the ability to be sup-
pressed by ITSA1. Because there was an unequal distribution of posi-
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Figure 2. Statistical Analysis of the Biological Activity of the 1,3-Dioxane Library
(A) Example of raw screening data of one 384-well plate from the AcTubulin and AcLysine assays with the relative acetylation level corresponding
to the fold change in signal compared to background.
(B) Average (n  7 plates) correlation of duplicate plates within the set of hydroxamic acids.
(C) Box plot showing summary of statistical properties of the screening data from the three structural classes of deacetylase inhibitors after
averaging duplicate data and Log2-transformation. Top and bottom numbers (black) are the highest and lowest extremes, respectively. Blue
numbers are the median values and red numbers the mean value for each distribution. The inner box represents the upper and lower bound
of the third and first quartile, respectively, which contains 50% of the distribution. The upper and lower bars represent 1.5-times the spread
of the third to first quartile with black/white dots representing small molecules outside this range.
(D) Number of bioactive small molecules and distribution amongst the three structural classes using a normalized acetylation value of 1.5 as
the criterion.
tives toward those small molecules containing hydrox- in AcHisH3, and 231 caused an increase in AcHisH4
(see Supplemental Table S1 at URL above).amic acids at diversity position R4 in both the AcTubulin
and AcLysine cytoblots, we focused subsequent
screening efforts on the 2464-member hydroxamic acid Suppression of -Tubulin Acetylation by the Chemical
subset of the 1,3-dioxane library. These compounds Genetic Modifier ITSA1
were screened in the AcTubulin assay in the presence Over the hydroxamic acid subset, the correlation be-
of chemical genetic modifier ITSA1, which suppresses tween the AcTubulin and AcTubulin  ITSA1 assays
trichostatin-induced histone and -tubulin acetylation remained significant (r 0.65, p value 0.05). However,
[21]. Two additional assays were employed to measure in the AcTubulin ITSA1 cytoblot, reduction in the num-
acetylation of histone H3 (AcHisH3) and histone H4 ber of positives (137 versus 475) indicates that ITSA1
(AcHisH4). Using the same statistical analyses and effectively suppressed many of the inducers of -tubulin
threshold used for the AcTubulin and AcLysine assays, acetylation. ITSA1-resistant small molecules are, in gen-
137 small molecules caused increased -tubulin acet- eral, among the most potent inducers of -tubulin acet-
ylation (Figure 3D). Interestingly, not all of the hydrox-ylation in the presence of ITSA1, 229 caused an increase
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Figure 3. Correlation between AcTubulin and
AcLysine Assays and Suppression of
-Tubulin Acetylation by ITSA1
(A) Linear correlation of the normalized acet-
ylation values of the 7392 members of the
1,3-dioxanes in the AcLysine and AcTubulin
assays.
(B) Six hundred seventeen of the total library
members with bioactivity using a 1.5-fold in-
crease in the normalized acetylation value as
the criterion (blue, active in both the AcTu-
bulin and AcLysine assays; green, active in
only the AcLysine assay; red, active in only
the AcTubulin assay).
(C) Venn diagram of the 617 bioactive small
molecules deconvoluted into selective and
overlapping sets.
(D) ITSA1 (50 M) suppressed the increased
-tubulin acetylation (yellow line) induced by
most but not all of the top 100 ranked posi-
tives in the AcTubulin assay (red line).
amic acids that induced -tubulin acetylation were are the subset of small molecules that scored in both
the AcTubulin and AcLysine assays, a portion of whichsuppressed by ITSA1, making it unlikely that ITSA1 re-
acts directly with this functional group. also scored in the ITSA1AcTubulin assay. Small mole-
cules not suppressed in ITSA1  AcTubulin are either
the most potent -tubulin deacetylase inhibitors or act
Representation of Screening Results mechanistically distinct from TSA. Thus, by further sub-
as a Chemical Genetic Network dividing small molecules based upon interaction with
To visualize patterns and compute global properties of ITSA1, five classes of deacetylase inhibitors with differ-
MDCG screening data, a general approach for analyzing ent patterns of bioactivity are observable in Gdeac.networks of interactions would be useful. Accordingly, Small molecules are now routinely compared by de-
using principles from graph theory [32] (see http:// composing their structures into components using mo-
vlado.fmf.uni-lj.si/pub/networks/pajek/), the screening lecular descriptors (e.g., cLogP, molecular weight, Chi
data were used to construct a symmetric, square adja- connectivity indices). By analogy, in order to quantify
cency matrix (Anxn). Here, n equals the number of verti- the information obtained in each assay and to compare
ces/nodes (V), representing an assay or one of the 617 the structure of the resulting networks, the adjacency
total active small molecules. In Anxn, each element aij  matrix Anxn was recursively decomposed into six subma-1 if the vertices vi and vj are connected by an edge (E), trices. To quantitatively compare these six networks,
which indicates the activity of compound vi in assay vj. we computed a set of three graph-theoretical descrip-
Alternatively, aij  0, which indicates the inactivity of tors for the corresponding networks (Figures 4B and 4C;
compound vi in assay vj. From the information encoded see http://vlado.fmf.uni-lj.si/pub/networks/pajek) [32].
in this adjacency matrix, the corresponding bipartite Based on the relative differences in these descriptors,
graph, Gdeac  (V, E), was constructed (Figure 4A). To the most complex subgraph was that of AcTubulin 
aid in visualization of the graph, we applied the Fruchter- AcLysine (A  B). Since the ITSA1  AcTubulin assay
man-Reingold algorithm (see URL above) [33]. This algo- (C) did not contribute new nodes to the graph (compare
rithm is a “spring embedder” that considers the graph A  B to complete graph A  B  C in Figure 4A), all
as a physical system composed of charged masses small molecules that scored in the ITSA1  AcTubulin
(vertices V) repelling each other and connecting springs assay (C) also scored in the AcTubulin assay (A). Overall,
(edges E) pulling adjacent vertices together. The algo- the AC and BC subgraphs were similar with respect
rithm minimizes the “energy” of the system when em- to the adjacency and Randic connectivity indices, but
bedding the graph into a two- or three-dimensional B C had a lower value for the Zagreb index, indicating
space. Overall, using a 1.5-fold minimum normalized lower vertex connectivity.
acetylation value as the criterion for 1,3-dioxane bioac-
tivity, the resulting graph (Gdeac) contains 620 nodes V
(617 from chemicals, 3 from assays), 956 edges E, and Global Analysis of Screening Data: Hierarchical
Clustering and Principal Component Analysishas a bipolar, spindle-like structure (Figure 4A). Here,
edges on the ends of the graph generally represent small A primary objective of this study was to determine the
similarity/differences of chemicals based upon their bio-molecules selective for either the AcTubulin or AcLysine
assays, as they radiate singly from their respective logical interactions or of biological assays based upon
their chemical interactions. Toward this end, standard-nodes. In the center of Gdeac are the most highly con-
nected nodes of the chemical genetic network. These ized covariance matrices were computed from the origi-
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Figure 4. Chemical Genetic Network from Screening Data
(A) Adjacency matrix and resulting graph (Gdeac) after applying the Fruchterman-Reingold “energy” minimization algorithm. Nodes represent
either assays or small molecules according to the indicated colors. Edges (black lines) connect bioactive small molecules to the corresponding
assay.
(B) “Retrosynthetic analysis” of Gdeac through decomposition into the subgraphs from all six combinations of assay data.
(C) Comparison of the information content in the six subgraphs, relative to the full graph, using graph-theoretical descriptors. The adjacency
index is defined to be the sum of the lengths of minimal paths between all pairs of vertices. Since all edges are of equal length in these
particular cases, this is equal to half the sum of all entries in the adjacency matrix: W  [Anxn]/2. The Zagreb M1 index is defined as the
sum of the squares of the vertex connectivities: Z  cn2, where cn is the number of edges from a particular vertex n. The Randic connectivity
index, which encodes information about branching, is defined as 1p   (cncm)1/2, where cn and cm are the number of edges of adjacent
vertices joined by each edge summed over all edges. For all three indices, a high value corresponds to a high percentage of the particular
type of topological property in the graph being analyzed.
nal chemical genetic data matrix using the Pearson cor- acid subset of the library across five different cell-based
assays. This analysis indicated the greatest similarityrelation coefficient. Covariance matrices are square,
symmetric matrices with off-diagonal elements repre- between the AcTubulin and ITSA1  AcTubulin data
sets when compared to any of the assays measuringsenting the correlation between descriptors. For all ob-
served phenotypes, MDCG assigns an n-dimensional histone acetylation levels (Figure 5A). Regarding the
three acetyl-histone assays, the AcHisH3 and AcHisH4operator,bio, represented by a standardized covariance
matrix that is computed globally across the set of n assays are more correlated to each other than either is
to the AcLysine assay. Overall, these results demon-biological assays. Similarly, for all observed chemicals,
MDCG assigns an m-dimensional operator, chem, repre- strate that while there is redundancy between the
assays, global differences exist in the window of biologysented by a standardized covariance matrix that is com-
puted globally across the set of m small molecules. described.
We next computed a principal component model ([34,This information can be further analyzed using clustering
algorithms and other methods of pattern finding. 35]; see Data Analysis under Experimental Procedures)
from the standardized covariance matrix of the hydrox-Clustering was applied to data from the hydroxamic
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Figure 5. Hierarchical Clustering and Principal Component Analysis of 2464 Hydroxamic Acids from a Five-Dimensional Chemical Genetic
Data Matrix
(A) Dendrogram from clustering the standardized covariance matrix of chemical genetic assay data (bio) using the unweighted pair-group
average method and Pearson correlation as the distance metric.
(B) The principal components are obtained by solving the algebraic eigenvalue problem:   Tbio, where  is the eigenvalue matrix, 
is the eigenvector matrix, bio is the standardized covariance matrix of chemical genetic assay data, and T denotes a transpose of a matrix.
 defines a coordinate transform (rotation) that best decorrelates the data into orthogonal linear subspaces. The chart shown plots the
location of the hydroxamic acids (blue dots) on the reduced space formed by the first and second principal components. Position and
structures of three of the decoded small molecules (colored) chosen for their overall activity are shown.
(C) Summary of variance accounted for by each eigenvalue (	1	5) and the contribution of each of the five original assay variables to the
principal component (
1–
5).
amic acid subset (Figure 5B). The result is a global model and use of this model in determining regions of selec-
tivity).that provides a visualizable representation of a chemical
space that minimizes the information lost upon projec-
tion of the elements into a reduced space of one to three Correlating Chemical Structure with Activity:
Hydroxamic Acids Are the Most Bioactivedimensions. Accordingly, principal components can be
used to position chemicals, with respect to the new Small Molecules across Assays
Seventeen small molecules exhibiting the highest levelssystem of coordinate axes, in terms of a linear combina-
tion of the original assay variables. Using this method, of activity in both the AcTubulin and AcLysine assays
were selected for bead decoding and structure determi-principal component analysis (PCA) revealed that 58%
of the information in the data set is accounted for in a nation (see Supplemental Figure S1 at ht tp :/ /www.
chembiol.com/cgi/content/full/10/5/383/DC1 or writeone-dimensional space represented by the first principal
component (
1). The second principal component (
2) to chembiol@cell.com for a PDF) [25, 30]. Notably, of
the 15 structures determined successfully, all are hy-represents a total of 22% of the information. Examina-
tion of the relative contribution of the different assays droxamic acids with six-carbon linkers. In addition, two
molecules were present in duplicate within the set ofand small molecules to the information represented on

1 indicated that this component represents a compos- 15, and both enantiomers of another molecule were
identified. When the position of each decoded com-ite measure of the activity of small molecules in all five
assays (Figure 5C; see below for details of structures pound was plotted in the reduced space formed by
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principal components 
1-
2, these identical or enantio- in the assay results, differences in stock solution con-
centration, impurities, or an insufficiently stringent mea-meric pairs were within very close proximity (Figure 5B).
Thus, the projection of a compound on 
1 is positively sure of selectivity. Since the majority of the selective
inhibitors in both the AcTubulin and AcLysine assays,correlated with a composite measure of bioactivity. Al-
though we have not yet determined the structure of all and all of the most potent deacetylase inhibitors, were
hydroxamic acids, the relative position of most of thesesmall molecules within this “high activity neighborhood”
across all five assays, we expect many of the other mole- compounds could be obtained using the three-dimen-
sional PCA model derived above using five assay de-cules in this region to share similar structural properties.
scriptors (Figure 6C). In this model, which accounts for
90.7% of the variance in the data, the AcTubulin-selec-
Correlating Chemical Structure with Selectivity: tive (red) and AcLysine-selective (green) sets clustered
the Most Selective Class of Small Molecules together and contributed less to the variation described
Varies between Assays by
1 then did either the full set of 2464 small molecules
In order to identify the most selective small molecules (inset; black spheres) or the most potent inhibitors (blue;
in both the AcTubulin and the AcLysine assays, PCA not all depicted).
was performed on each structural class of 1,3-dioxanes
defined by the three functionalities incorporated at posi- Tubacin, a Selective Inducer
tion R4 (Figure 1B). As this analysis used data from the of -Tubulin Acetylation
two assays in which the entire library was screened Two small molecules were chosen as selective inducers
(AcTubulin and AcLysine), the input space was two- of -tubulin acetylation, based upon their position in the
dimensional. As such, PCA centered the data based on rotated space of 
1-
2. No apparent selectivity was
the distribution centroid and rotated the original axes as observed for one of these molecules (413 D10) when a
specified by the eigenvectors, without any information sample was tested in the secondary fluorescence mi-
loss. As shown (Figure 6A), for both o-aminoanilides and croscopy assays for acetylated -tubulin and acetylated
carboxylic acids, the two eigenvalues (	1- 	2) account lysine. This discrepancy might arise from higher com-
for roughly equal amounts of the variance. This corre- pound concentrations in the secondary assay of (10
sponds to low activity of these sets of small molecules M versus a 2–5 M screening concentration) or in-
and low correlation between bioactivity in one assay creased sensitivity in the fluorescence microscopy
versus the other. Indeed, none of the 2464 o-aminoani- assay. However, the second compound 415 N3 (Figure
lides showed any activity toward inhibiting -tubulin 7A), here named tubacin (1) (tubulin acetylation inducer)
deacetylation, while 0.5% of these small molecules in- strongly increased -tubulin acetylation with no effect
hibited histone deacetylation (Figure 2D). The o-amino- on lysine acetylation. This small molecule was resynthe-
anilide functionality may therefore provide an effective sized to allow a systematic assessment of the effect on
means to target histone deacetylation without affecting -tubulin and histone acetylation. Treatment of A549
-tubulin acetylation levels (see [22] for more details). cells with tubacin (19 hr) strongly increased -tubulin
In contrast, 	1 accounted for more than 80% of the acetylation levels (Figure 7B) at concentrations as low
variance in the set of hydroxamic acids, which were on as 125 nM (4 hr, data not shown). Consistent with the
average more active than either the o-aminoanilides or original screening data, tubacin did not affect histone
carboxylic acids. This difference in eigenvalue magni- acetylation and was partially suppressed by ITSA1 (Fig-
tude corresponds to the high degree of bioactivity and ure 7B). Thus, tubacin is the first known selective inhibi-
strong correlation between the AcTubulin and AcLysine tor of -tubulin deacetylation.
assays. Consequently, one principal component is ca- In the three-dimensional PCA model (Figure 6C), the
pable of representing the majority of the information. The most proximal compound to tubacin (415 N3) was 415
resulting bioactivity distributions on 
1-
2 are shown in O6. This compound had the identical structure as an-
Figure 6B. Based upon the average activity of the class other decoded compound, 418 D6, which was also
of small molecules and position within the rotated space among the closest in proximity to tubacin in the three-
of the principal components, a set of small molecules dimensional PCA model (Figure 6C). Notably, 415 O6/
was chosen for bead decoding and structure determina- 418 D6 is one of the1.4% of the total library members
tion (see Supplemental Figures S2 and S3 at http://www. (not considering stereochemistry) that share the same
chembiol.com/cgi/content/full/10/5/383/DC1 or write to building blocks at three of the four diversity positions
chembiol@cell.com for a PDF) [23, 28] Twenty-four of (R2-R4) as tubacin. Furthermore, at the position that is
these were selective for the AcTubulin assay, and 22 different from tubacin (R1), the 2-mercaptopyridine
were selective for the AcLysine assay. Calculated group shares some structural similarity to the core of
masses of the inferred chemical structures matched the 4,5-diphenyl-2-oxazolethiol building block present
those determined by liquid-chromatographic mass in tubacin. In agreement with these structural similari-
spectrometric analysis of the corresponding stock solu- ties, retesting of the original stock solution of 418 D6
tions (data not shown). However, because chemical- using fluorescence microscopy confirmed its selective
encoding strategies record chemical history only, these inhibition of -tubulin deacetylation (data not shown).
structural assignments should be considered tentative.
Following decoding, we noted that one structure, from Histacin, a Selective Inducer
two different plate positions, was common to both the of Histone Acetylation
AcLysine (418 B2) and AcTubulin (416 N3) selective lists. Two small molecules were chosen as selective inducers
of histone acetylation based upon their position in theThis anomalous result may be due to statistical variation
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Figure 6. Principal Component Analysis of
Diversity Position R4
(A) Eigenvalue spectrum and variance associ-
ated with the three structural classes of de-
acetylase inhibitors.
(B) Charts plotting a random sample of 10%
of the small molecules (blue dots) of each
structural class on the rotated space of 
1
and 
2. The location of histacin and tubacin,
selective inhibitors of histone and -tubulin
deacetylation, respectively, are shown.
(C) Relative position of decoded structures
(see Supplemental Figures S1–S3 at http://
www.chembiol.com/cgi/content/full/10/5/
383/DC1 or write to chembiol@cell.com for a
PDF) in a PCA model computed from five cell-
based assay descriptors (see Figure 5C). Ac-
Tubulin selective, red; AcLysine selective,
green; and most potent, blue.
rotated space of 
1-
2. Again, no selectivity was ob- tone acetylation cannot be suppressed by ITSA1 (data
not shown).served for one of these small molecules (417 A20) when
tested in the secondary fluorescence microscopy
assays for acetylated -tubulin and acetylated lysine. Discussion
However, the second compound 410 F1 (Figure 7C),
here named histacin (2) (histone acetylation inducer), Classical genetics began annotating genetic factors by
observing heritability and determining the linkage ofstrongly increased lysine acetylation with no effect on
-tubulin acetylation (Figure 7D). After resynthesis, simple phenotypic traits. Using these observations and
the frequency of recombination during the first meiotictreatment (14 hr) of cells with histacin (20 M) increased
acetylated histone levels without affecting -tubulin division as a metric, the relative distance between genes
encoding for phenotypes was experimentally defined,acetylation levels. Thus, histacin, like the epoxy ketone-
containing HDAC inhibitors trapoxin and HC toxin, is a one map unit being equal to 1% recombination (mea-
sured in cM) [36]. Accordingly, a mutant gene could beselective inhibitor of histone deacetylation. Further-
more, like trapoxin/HC toxin, histacin’s effects on his- “mapped” as a point in a one-dimensional space. Through
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Figure 7. Selective Inhibitors of -Tubulin and Histone Deacetylation
(A) Chemical structure of tubacin (compound 415 N03).
(B) Effect of tubacin (2 M) and trichostatin (2 M) treatment (19 hr) on the acetylation level of -tubulin (red) in A549 cells measured by
immunofluorescence. Western blot analysis of acetylated -tubulin and acetylated histone H3 (K9, K14) in A549 cells pretreated (2 hr) with
tubacin (2 M) followed by ITSA1 (50 M) for an additional 2 hr. See [22] for further analysis of tubacin and its inhibition of HDAC6.
(C) Chemical structure of histacin (compound 410 F1).
(D) Effect of histacin (20 M) and trichostatin (300 nM) treatment (5 hr) on the acetylation level of histone H3 (yellow/green) in A549 cells
measured by immunofluorescence. Western blot analysis of acetylated -tubulin and acetylated histone H3 (K9, K14) in histacin (20 M)
treated (5 hr) A549 cells. See [24] for further analysis of 410 F01 (histacin).
(E) Network of genetic and chemical genetic interactions among 1,3-dioxane-based deacetylase inhibitors.
overlapping distance measurements, a genetic map By analogy to the logic of classical genetics, we are
interested in creating “chemical genetic maps” that po-could be constructed. Although not obvious at the onset,
it is now well known that such maps represent the physi- sition chemicals and biological systems in a multidimen-
sional space. Such maps will facilitate systematic analy-cal arrangement of genes within a linear and continuous
sequence of deoxyribonucleic acids. sis of the factors determining interactions between small
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molecules and biological systems. At the core of such ponent analysis [34, 35]. This eigenvalue/eigenvector
approach takes into account the global properties ofefforts is the relationship between information present
in chemical genetic observations and mathematical the space spanned by the variables under study. In
doing so, it reduced the probability of selecting a com-quantities that make up the geometric properties of vec-
tor spaces. While chemical space is often considered a pound as selective only due to a technical error or the
compound having an undesired cellular effect. Althoughvector space with dimensions represented by calculated
molecular descriptors, we instead focused on measur- we considered only a two-dimensional space spanned
by 
1 and 
2, the logic of this analysis holds upon theing the similarity/differences of small molecules using
phenotypic properties from cell-based assays. Pioneer- addition of more dimensions. Thus, PCA is well suited
for the discovery of molecules with complex phenotypicing work by the group of Dr. John Weinstein demon-
strated that data sets representing interactions of small effects, and not just activity in one particular assay. In
the global analysis of the hydroxamic acids in the fivemolecules with tumor cell lines were rich in information
[35–38]. Although limited to a single phenotype (cellular assays, the first eigenvalue (	1) accounted for most of
the information in the data set and correlated with thegrowth as measured by protein production), this analy-
sis was able to classify small molecules into similar bioactivity of the small molecules. In the discovery of
selective inhibitors of -tubulin deacetylation or histonepatterns of activity and tumor cell lines into similar
groups. Here, the logic of this type of analysis is applied deacetylation, the two- and three-dimensional PCA
models delineated regions of chemical space with differ-to a set of biochemical phenotypes, specifically acetyla-
tion levels of -tubulin and histones in cells. In addition, ent patterns of bioactivity (Figures 6B and 6C). Besides
allowing for a more informative visualization of multidi-the small molecules screened derive from a biased li-
brary rather than a “random” collection. Our initial analy- mensional data, PCA has a practical application for data
analysis, as the reduced number of dimensions simpli-ses were limited to one genotype (that of a human lung
cancer cell line) and thus could be expanded to include fies subsequent computations that may be memory and
time intensive.varying cell types and/or genotypes.
Genes can have multiple functions, as observed by The possibility exists that both tubacin and histacin
affect the acetylation levels of proteins other thanmultiple phenotypic effects resulting from their muta-
tion. Similarly, small molecules can have multiple func- -tubulin and histones, respectively. Future work with
the small molecules discovered here will be directedtions, as observed by multiple phenotypic effects re-
sulting from their interaction with cellular components. toward determining their potency and testing for differ-
ential phenotypes on gene expression, stem cell differ-The distribution of activities in a given assay, correlation
across assays, and the relationships of the assays them- entiation, and zebrafish embryogenesis. With the re-
maining amount from each stock solution, additionalselves renders the number of comparisons required to
find certain patterns of activity intractable. Accordingly, screens of the 1,3-dioxane library will be aimed at de-
termining the extent to which the small molecules affectmodeling and visualizing multidimensional data requires
the use of dimensionality reduction and pattern finding other histone modifications, metalloenzymes (i.e., deu-
biquitinases and proteases), and other biological pro-algorithms. This allows higher-level representation of
the information inherent in lower-level relational data. cesses.
An outstanding question in the field of chemical biol-For this purpose, we introduced the concept of a
chemical genetic network for the analysis of screening ogy is how best to quantify molecular diversity in a way
that informs biological discovery. Although moleculardata. If two small molecules score in the same pheno-
typic assay, then there is some probability that they are descriptors based upon a chemical graph (structure) are
generally trivial to compute, structure-activity relation-hitting the same target. However, if the same two small
molecules exhibit different patterns of biological activity ships are often complex. As an alternative, the effective-
ness of diversity-oriented syntheses can be quantifiedin other phenotypic assays, the probability that they are
targeting the same gene product is reduced. Thus, the by the dimensionality of the biological space required
to effectively describe the observed phenotype. For ex-connectivity of a chemical node can be used to constrain
the set of possible targets and to provide a discrete ample, had the 1,3-dioxane library been composed of
o-aminoanilides alone, all molecules could have beenmeasure of a small molecule’s selectivity. Similarly, the
connectivity of an assay node can be used to compare positioned on a one-dimensional space, since none of
them scored in the AcTubulin assay. In contrast, a 1,3-the aspects of a biological system being queried and
to provide a discrete measure of an assay’s sensitivity. dioxane library composed solely of hydroxamic acids
would require two dimensions, one for AcLysine andAlthough the network constructed here was based upon
an empirically defined threshold, similar networks could AcTubulin. Thus, through systematic screens of small
molecule libraries in minimally redundant, maximally in-be formed at different levels of bioactivity. Furthermore,
rather than using a binary edge length ( 0 or 1), the formative cell-based assays, maps of chemical space
can be derived from biologically based descriptors.lengths could be made proportional to the bioactivity of
a compound or a likelihood score. As the annotation and Such maps may have more distinct geometric and topo-
logical properties than those derived from calculatedsubdivision of a chemical genetic network increases,
predictions of whether a new member of a class will descriptors.
The utility of antibodies to detect specific posttransla-have additional targets within a cell or will interact with
a specific chemical genetic modifier may be possible. tional modifications in high-throughput phenotypic
assays provides a powerful approach to identifyingAs another form of multidimensional data analysis,
we used a computational method called principal com- novel biologically active small molecules [9, 11, 21, 38].
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from Chembridge. Anti-acetylated lysine antibody was purchasedThis complete screen consumed less than 20% (20
from Cell Signaling. Anti-acetyl histone H3 (K9, K14) and anti-acetylnmol) of the compound released from one synthesis
histone H4 (K4, K7, K11, K15) antibodies were purchased from Up-bead, leaving the majority of compound for retesting,
state Biotechnology. Anti-mouse IgG horseradish peroxidsae (HRP)
analytical analysis, or subsequent additional screening. conjugated, anti-rabbit IgG-HRP conjugated secondary antibodies,
The overall high level of observed activity (8% of library and enhanced chemiluminescent mixture (luminol) were purchased
from Amersham Pharmacia. Alexa 594 and Alexa 488-conjugatedsmall molecules active) at a concentration of 2–5 M
anti-mouse IgG antibody, anti-rabbit IgG antibody, and Hoechstreflects prior knowledge guiding library synthesis, as
33342 were purchased from Molecular Probes.well as apparent sensitivity of HDACs to small molecule
modulation. While a number of small molecules (80)
Cell Culture
have previously been reported to inhibit HDAC activity A549 human lung carcinoma cells (American Tissue Culture Collec-
in vitro, only a limited set of these appear to be effective tion) were cultured at 37C with 5% carbon dioxide in Dulbecco’s
inhibitors of HDAC activity within the context of living modified Eagle’s medium (DMEM) supplemented with 10% v/v fetal
bovine serum (Gibco BRL), 100 units/ml penicillin G sodium (Gibcocells [19, 20]. Since the cell-based screening methodol-
BRL), 100 g/ml streptomycin sulfate (Gibco BRL), and 2 mMogy described in this paper is scalable and can be gener-
L-glutamine (Gibco BRL) (DMEM).alized to other posttranslational modifications, the de-
velopment of additional assays coupled to important
1,3-Dioxane Library Screen and Cytoblot Assays
biological processes is possible. In particular, iterative A549 cells were seeded at a density of 4000 cells/50 l in DMEM
cycles of chemical genetic modifier screens, using in white tissue culture-treated 384-well plates (Nalge Nunc) using a
newly discovered bioactive small molecules, should fa- Multidrop 384 liquid dispenser (Labsystems). Library small mole-
cules were pinned twice (100–150 nl/pin) from 1 mM stock solu-cilitate the construction of chemical genetic networks
tions (DMSO) and incubated for 18 hr. For the ITSA1  AcTubulinfor use in “chemical genomic profiling” experiments. An
assay, ITSA1 (50 M) was added four hours after pin transfer ofimportant direction in such studies will be the develop-
library molecules. Media was aspirated with a 16-channel wand. For
ment of novel screening methodologies with increased the acetylated -tubulin cytoblot (AcTubulin), 40 l/well of fixation
efficiency, information content, and accuracy. Here, the solution (3.7% formaldehyde [1:10 from 37% stock] in Tris-buffered
combination of small molecules and RNAi-based pertur- saline [TBS; 0.15 M NaCl, 0.02 M Tris-Cl pH 7.4]) was added, and
plates were incubated for 20 min at room temperature. After aspira-bations promises to be an illuminating direction of re-
tion, 30 l 100% methanol (20C) was added and incubated for 5search. In parallel, along with increasing the diversity of
min at room temperature. After aspirating and washing three timessmall molecule modulators, deconvolution of synthetic
with 90 l of antibody dilution buffer (ADB; TBS/2% bovine serumvariables, such as efficiency and purity, will continue to
albumin, 0.1% Triton X-100), the wells were blocked for 20 min in
be required. In the limit, beyond traditional functional char- ADB. After aspirating, 20 l/well of ADB containing anti-acetylated
acterization, one can imagine annotating proteins en- -tubulin antibody (mouse; 1:1000) and anti-mouse IgG horseradish
coded within an entire genome using a set of small mole- peroxidase (HRP)-conjugated antibody (1:750) was added and incu-
bated overnight (4C). For the anti-acetyl lysine cytoblot (AcLysine),cule modulators of their biochemical activities [4, 10].
40 l/well of fixation solution (95% ethanol/5% acetic acid, 20C)
was added, and plates were incubated for 5 min at room tempera-Significance
ture. Wells were aspirated, washed, and blocked in ADB as for the
AcTubulin protocol. After aspirating, 20 l/well of ADB containing
The identification of 617 small molecule inhibitors of anti-acetylated lysine (rabbit; 1:375) and anti-rabbit IgG-HRP conju-
intracellular deacetylation highlights multidimensional gated antibody (1:750) was added and incubated overnight (4C).
For the anti-acetylated histone H3 (AcHistH3) and anti-acetylatedchemical genetics and diversity-oriented organic syn-
histone H4 (AcHistH4) cytoblots, cells were fixed, washed, andthesis as tools for the discovery of probes of complex
blocked in ADB as for the AcLysine cytoblot. After aspirating, 20 l/biological networks. New small molecules with dia-
well of ADB containing anti-acetylated histone H3 antibody (rabbit,
metrically opposed inhibitory activities (tubacin/ 1:500) or anti-acetylated histone H4 antibody (rabbit, 1:500) was
tubulin deacetylase inhibitor versus histacin/histone added and incubated for 2 hr at room temperature. Wells were
deacetylase inhibitor) provide a means to dissect the aspirated and washed twice with 80 l of ADB. After aspirating, 20
l/ well of ADB containing anti-rabbit IgG-HRP conjugated antibodyrole of acetylation in microtubule dynamics and chro-
(1:1000) was added and incubated for 2 hr (room temperature). Formatin remodeling [21, 22, 24]. The discovery of potent
the AcTubulin and AcLysine assays, plates were washed three timesand especially selective deacetylase inhibitors was
with TBS before adding 20 l/well of enhanced chemiluminescentpossible through computational methods, most nota-
(ECL) mixture. For the AcHistH3 and AcHistH4 assays, plates were
bly principal component analysis and consideration washed three times with 80 l TBS with 1% Triton X-100 and once
of proximity in multidimensional descriptor spaces. with 80 l TBS before adding 20 l/well of ECL mixture. Plates were
Using the principles of graph theory, a discrete model read on an Analyst plate reader (LJL Biosystems) with an integration
time of 0.1 s.of the screening data was derived in the form of a
“chemical genetic network” and analyzed using topo-
Chemical Library and Retesting of Positiveslogical invariants. By systematically mapping the
1,3-dioxanes from single polystyrene macrobeads were preparedstructure-activity relationships of this particular “de-
as 1–2 mM stock solutions in DMSO as described [23, 28]. Bead
acetylase” region of chemical space, the results of decoding and structure determination were as described [23, 29].
this study should assist in the discovery of selective Small molecules (2–5 M) of interest were retested using a sample
HDAC inhibitors that may be more effective research from the plate of stock solutions by fluorescence microscopy and
comparison to the effects of trichostatin (300 nM to 1 M).tools and therapeutic agents.
ImmunofluorescenceExperimental Procedures
A549 cells were seeded at a density of 50,000/ 200 l in DMEM
on the surface of glass coverslips on top of Parafilm in a 10 cmTrichostatin A (TSA) and anti-acetylated -tubulin (6-11B-1) anti-
body were purchased from Sigma. ITSA1 (5253409) was purchased dish and allowed to attach overnight. For detection of acetylated
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-tubulin, cells were permeabilized and fixed with 100 mM K-PIPES References
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aldehyde for 15 min.Coverslips were aspirated and excess glutaral- 1. Jeong, H., Tombor, B., Albert, R., Oltvai, Z.N., and Barabasi,
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